Zkusit zdarma
Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, Inc.

DCPH
Cena:
 
 
Valuace
70
Růst
30
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Deciphera Announces the Opening of a New Office in Zug, Switzerland

Deciphera Announces the Opening of a New Office in Zug, Switzerland

1:00 17-11-2025

OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, J...

Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 2025

Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 2025

7:00 18-10-2025

OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, J...

Deciphera Receives European Commission Approval of ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)

Deciphera Receives European Commission Approval of ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)

15:46 17-09-2025

OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, J...

Deciphera Announces Positive CHMP Opinion for ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)

Deciphera Announces Positive CHMP Opinion for ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)

7:00 28-07-2025

OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, LLC, a biopharmaceutical ...

U.S. FDA Grants Full Approval of Deciphera's ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)

U.S. FDA Grants Full Approval of Deciphera's ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)

18:50 14-02-2025

OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, J...

European Medicines Agency Accepts Deciphera's Marketing Authorization Application for Vimseltinib for Treatment of Patients with Tenosynovial Giant Cell Tumor (TGCT)

European Medicines Agency Accepts Deciphera's Marketing Authorization Application for Vimseltinib for Treatment of Patients with Tenosynovial Giant Cell Tumor (TGCT)

20:00 18-07-2024

OSAKA, Japan & WALTHAM, Mass.--(BUSINESS WIRE)--Ono Pharmaceutical, Co., Ltd. (Headquarters: Osaka, ...

Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The Lancet

Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The Lancet

7:00 03-06-2024

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical...

Deciphera's (DCPH) Shares Surge 74.3% in a Month: Here's Why

Deciphera's (DCPH) Shares Surge 74.3% in a Month: Here's Why

14:15 23-05-2024

Deciphera (DCPH) soars 74.3% in the past month on a $2.4 billion buy-out offer from ONO Pharmaceutic...

Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings

Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings

10:30 10-05-2024

While the top- and bottom-line numbers for Deciphera Pharmaceuticals (DCPH) give a sense of how the ...

Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates

Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates

9:51 10-05-2024

Deciphera Pharmaceuticals, Inc. (DCPH) came out with a quarterly loss of $0.52 per share versus the ...

Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion

Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion

3:44 30-04-2024

Japan's Ono Pharmaceutical Co said on Tuesday its $2.4 billion takeover of Deciphera Pharmaceuticals...

ONO to buy Deciphera Pharmaceuticals at a huge premium

ONO to buy Deciphera Pharmaceuticals at a huge premium

11:19 29-04-2024

Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) is up a whopping 75% today after ONO Pharmaceutical (TY...

Why Is Deciphera Pharmaceuticals (DCPH) Stock Up 72% Today?

Why Is Deciphera Pharmaceuticals (DCPH) Stock Up 72% Today?

10:33 29-04-2024

Deciphera Pharmaceuticals (NASDAQ: DCPH ) stock is rising higher on Monday after signing a $2.4 bill...

Deciphera Pharmaceuticals Is Being Acquired and the Stock Soars 71%

Deciphera Pharmaceuticals Is Being Acquired and the Stock Soars 71%

9:01 29-04-2024

Deciphera Pharmaceuticals is being bought by Japan's ONO Pharmaceutical in a deal valued at $2.4 bil...

Japan's ONO Pharmaceutical to buy Deciphera for $2.4 billion

Japan's ONO Pharmaceutical to buy Deciphera for $2.4 billion

7:08 29-04-2024

Deciphera Pharmaceuticals said on Monday Japan's ONO Pharmaceutical Co will acquire the company for ...

Why Is Deciphera Pharmaceuticals, Inc. (DCPH) Up 20.8% Since Last Earnings Report?

Why Is Deciphera Pharmaceuticals, Inc. (DCPH) Up 20.8% Since Last Earnings Report?

12:36 07-03-2024

Deciphera Pharmaceuticals, Inc. (DCPH) reported earnings 30 days ago. What's next for the stock?...

Wall Street Analysts Think Deciphera Pharmaceuticals, Inc. (DCPH) Could Surge 48.49%: Read This Before Placing a Bet

Wall Street Analysts Think Deciphera Pharmaceuticals, Inc. (DCPH) Could Surge 48.49%: Read This Before Placing a Bet

10:56 28-02-2024

The consensus price target hints at a 48.5% upside potential for Deciphera Pharmaceuticals, Inc. (DC...

Wall Street Analysts Believe Deciphera Pharmaceuticals, Inc. (DCPH) Could Rally 59.63%: Here's is How to Trade

Wall Street Analysts Believe Deciphera Pharmaceuticals, Inc. (DCPH) Could Rally 59.63%: Here's is How to Trade

10:56 12-02-2024

The average of price targets set by Wall Street analysts indicates a potential upside of 59.6% in De...

Deciphera (DCPH) Q4 Loss Narrower Than Expected, Revenues Beat

Deciphera (DCPH) Q4 Loss Narrower Than Expected, Revenues Beat

9:31 07-02-2024

Deciphera (DCPH) reports better-than-expected fourth-quarter 2023 results, wherein both earnings and...

Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call and Webcast on February 6, 2024

Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call and Webcast on February 6, 2024

16:50 01-02-2024

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical...

close

DECIPHERA ANNOUNCES ORAL PRESENTATION OF POSITIVE TOPLINE RESULTS FROM PHASE 2A STUDY OF SAPABLURSEN IN POLYCYTHEMIA VERA AT THE 67TH AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING

06-12-2025
OSAKA, JAPAN & WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, A MEMBER OF ONO PHARMACEU...
Více zde

DECIPHERA ANNOUNCES THE OPENING OF A NEW OFFICE IN ZUG, SWITZERLAND

17-11-2025
OSAKA, JAPAN & WALTHAM, MASS.--(BUSINESS WIRE)--ONO PHARMACEUTICAL CO., LTD. (HEADQUARTERS: OSAKA, J...
Více zde

DECIPHERA ANNOUNCES MULTIPLE DATA PRESENTATIONS AT THE CONNECTIVE TISSUE ONCOLOGY SOCIETY (CTOS) ANNUAL MEETING 2025

12-11-2025
OSAKA, JAPAN & WALTHAM, MASS.--(BUSINESS WIRE)--ONO PHARMACEUTICAL CO., LTD. (HEADQUARTERS: OSAKA, J...
Více zde

DECIPHERA PRESENTS 2-YEAR EFFICACY AND SAFETY RESULTS FROM MOTION PHASE 3 STUDY OF ROMVIMZA™ (VIMSELTINIB) IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY CONGRESS 2025

18-10-2025
OSAKA, JAPAN & WALTHAM, MASS.--(BUSINESS WIRE)--ONO PHARMACEUTICAL CO., LTD. (HEADQUARTERS: OSAKA, J...
Více zde

DECIPHERA RECEIVES EUROPEAN COMMISSION APPROVAL OF ROMVIMZA™ (VIMSELTINIB) FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR (TGCT)

17-09-2025
OSAKA, JAPAN & WALTHAM, MASS.--(BUSINESS WIRE)--ONO PHARMACEUTICAL CO., LTD. (HEADQUARTERS: OSAKA, J...
Více zde

DECIPHERA ANNOUNCES POSITIVE CHMP OPINION FOR ROMVIMZA™ (VIMSELTINIB) FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR (TGCT)

28-07-2025
OSAKA, JAPAN & WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, LLC, A BIOPHARMACEUTICAL ...
Více zde

U.S. FDA GRANTS FULL APPROVAL OF DECIPHERA'S ROMVIMZA™ (VIMSELTINIB) FOR THE TREATMENT OF SYMPTOMATIC TENOSYNOVIAL GIANT CELL TUMOR (TGCT)

14-02-2025
OSAKA, JAPAN & WALTHAM, MASS.--(BUSINESS WIRE)--ONO PHARMACEUTICAL CO., LTD. (HEADQUARTERS: OSAKA, J...
Více zde

EUROPEAN MEDICINES AGENCY ACCEPTS DECIPHERA'S MARKETING AUTHORIZATION APPLICATION FOR VIMSELTINIB FOR TREATMENT OF PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT)

18-07-2024
OSAKA, JAPAN & WALTHAM, MASS.--(BUSINESS WIRE)--ONO PHARMACEUTICAL, CO., LTD. (HEADQUARTERS: OSAKA, ...
Více zde

DECIPHERA PHARMACEUTICALS ANNOUNCES ORAL PRESENTATION OF RESULTS FROM MOTION PIVOTAL PHASE 3 STUDY OF VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AT THE 2024 ASCO ANNUAL MEETING AND ONLINE PUBLICATION IN THE LANCET

03-06-2024
WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH), A BIOPHARMACEUTICAL...
Více zde

DECIPHERA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF DECIPHERA PHARMACEUTICALS, INC. - DCPH

01-05-2024
NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND TH...
Více zde

INVESTIGATION: THE M&A CLASS ACTION FIRM ANNOUNCES AN INVESTIGATION OF DECIPHERA PHARMACEUTICALS, INC. - DCPH

29-04-2024
NEW YORK , APRIL 29, 2024 /PRNEWSWIRE/ -- MONTEVERDE & ASSOCIATES PC (THE "M&A CLASS ACTION FIRM"), ...
Více zde

SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER DECIPHERA PHARMACEUTICALS, INC. HAS OBTAINED A FAIR PRICE IN ITS TRANSACTION WITH ONO PHARMACEUTICAL CO.

29-04-2024
MILWAUKEE , APRIL 29, 2024 /PRNEWSWIRE/ -- ADEMI LLP IS INVESTIGATING DECIPHERA (NASDAQ: DCPH) FOR ...
Více zde

DCPH STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF DECIPHERA PHARMACEUTICALS, INC. IS FAIR TO SHAREHOLDERS

29-04-2024
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde

DECIPHERA PHARMACEUTICALS TO BE ACQUIRED BY ONO PHARMACEUTICAL FOR $2.4 BILLION

29-04-2024
WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH), A BIOPHARMACEUTICAL...
Více zde

SHAREHOLDER ALERT: PURCELL & LEFKOWITZ LLP ANNOUNCES SHAREHOLDER INVESTIGATION OF DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH)

18-04-2024
NEW YORK , APRIL 18, 2024 /PRNEWSWIRE/ -- PURCELL & LEFKOWITZ LLP ANNOUNCES THAT IT IS INVESTIGATING...
Více zde

DECIPHERA PHARMACEUTICALS TO PRESENT AT THE STIFEL 2024 VIRTUAL TARGETED ONCOLOGY FORUM

09-04-2024
WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH), A BIOPHARMACEUTICAL...
Více zde

DECIPHERA PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

27-02-2024
WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH), A BIOPHARMACEUTICAL...
Více zde

DECIPHERA PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

06-02-2024
WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH), A BIOPHARMACEUTICAL...
Více zde

DECIPHERA PHARMACEUTICALS TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND HOST CONFERENCE CALL AND WEBCAST ON FEBRUARY 6, 2024

01-02-2024
WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH), A BIOPHARMACEUTICAL...
Více zde

DECIPHERA PHARMACEUTICALS TO PRESENT AT THE GUGGENHEIM HEALTHCARE TALKS 6TH ANNUAL BIOTECHNOLOGY CONFERENCE

01-02-2024
WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH), A BIOPHARMACEUTICAL...
Více zde

DECIPHERA PHARMACEUTICALS PRESENTS LONG-TERM FOLLOW-UP RESULTS FROM INTRIGUE PHASE 3 CLINICAL STUDY IN SECOND-LINE GIST PATIENTS AT THE 2024 AMERICAN SOCIETY OF CLINICAL ONCOLOGY GASTROINTESTINAL CANCERS SYMPOSIUM

18-01-2024
WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH), A BIOPHARMACEUTICAL...
Více zde

GENESIS PHARMA ANNOUNCES AN EXCLUSIVE DISTRIBUTION AGREEMENT WITH DECIPHERA PHARMACEUTICALS TO COMMERCIALIZE RIPRETINIB IN 14 EU MARKETS IN CENTRAL AND EASTERN EUROPE

12-01-2024
ATHENS, GREECE--(BUSINESS WIRE)--GENESIS PHARMA ANNOUNCES DISTRIBUTION AGREEMENT WITH DECIPHERA PHAR...
Více zde

DECIPHERA PHARMACEUTICALS ANNOUNCES PLANNED 2024 CORPORATE MILESTONES SUPPORTING EVOLUTION TO A SELF-SUSTAINING, MULTI-PRODUCT COMPANY

08-01-2024
WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH), A BIOPHARMACEUTICAL...
Více zde

DECIPHERA PHARMACEUTICALS ANNOUNCES NATURE MEDICINE PUBLICATION OF RESULTS FROM EXPLORATORY CTDNA ANALYSIS FROM INTRIGUE PHASE 3 STUDY DEMONSTRATING SUBSTANTIAL CLINICAL BENEFIT OF QINLOCK® IN 2L GIST PATIENTS WITH MUTATIONS IN KIT EXON 11 AND 17/18

05-01-2024
WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH), A BIOPHARMACEUTICAL...
Více zde

DECIPHERA PHARMACEUTICALS TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

02-01-2024
WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH), A BIOPHARMACEUTICAL...
Více zde

DECIPHERA PHARMACEUTICALS TO PRESENT AT THE JMP SECURITIES HEMATOLOGY AND ONCOLOGY SUMMIT

29-11-2023
WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH), A BIOPHARMACEUTICAL...
Více zde

DECIPHERA PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

07-11-2023
WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH), A BIOPHARMACEUTICAL...
Více zde

DECIPHERA PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS

30-10-2023
WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH), A BIOPHARMACEUTICAL...
Více zde

DECIPHERA PHARMACEUTICALS ANNOUNCES POSITIVE TOP-LINE RESULTS FROM MOTION PIVOTAL PHASE 3 STUDY OF VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND UPDATED RESULTS FROM PHASE 1/2 STUDY OF VIMSELTINIB IN TGCT

30-10-2023
WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH), A BIOPHARMACEUTICAL...
Více zde

DECIPHERA PHARMACEUTICALS, INC. ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

15-09-2023
WALTHAM, MASS.--(BUSINESS WIRE)--DECIPHERA PHARMACEUTICALS, INC. (NASDAQ: DCPH), A BIOPHARMACEUTICAL...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2024-06-11 01:00:008-KStáhnout
2024-06-11 00:00:008-KStáhnout
2024-05-10 01:00:0010-QStáhnout
2024-05-10 00:00:0010-QStáhnout
2024-04-29 01:00:008-KStáhnout
2024-04-29 00:00:008-KStáhnout
2024-02-07 00:00:0010-KStáhnout
2024-02-06 23:00:0010-KStáhnout
2024-02-06 00:00:008-KStáhnout
2024-02-05 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-10-30 00:00:008-KStáhnout
2023-10-30 00:00:0010-QStáhnout
2023-10-29 23:00:008-KStáhnout
2023-10-29 23:00:0010-QStáhnout
2023-08-09 01:00:008-KStáhnout
2023-08-09 01:00:0010-QStáhnout
2023-08-09 00:00:008-KStáhnout
2023-08-09 00:00:0010-QStáhnout
2023-08-03 01:00:008-KStáhnout
2023-08-03 00:00:008-KStáhnout
2023-06-22 01:00:008-KStáhnout
2023-06-22 00:00:008-KStáhnout
2023-05-03 01:00:008-KStáhnout
2023-05-03 01:00:0010-QStáhnout
2023-05-03 00:00:008-KStáhnout
2023-05-03 00:00:0010-QStáhnout
2023-02-07 00:00:008-KStáhnout
2023-02-07 00:00:0010-KStáhnout
2023-02-06 23:00:008-KStáhnout
2023-02-06 23:00:0010-KStáhnout
2023-01-20 00:00:008-KStáhnout
2023-01-19 23:00:008-KStáhnout
2023-01-18 00:00:008-KStáhnout
2023-01-17 23:00:008-KStáhnout
2023-01-03 00:00:008-KStáhnout
2023-01-02 23:00:008-KStáhnout
2022-11-03 00:00:008-KStáhnout
2022-11-03 00:00:0010-QStáhnout
2022-11-02 23:00:008-KStáhnout
2022-11-02 23:00:0010-QStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 01:00:0010-QStáhnout
2022-08-04 00:00:008-KStáhnout
2022-08-04 00:00:0010-QStáhnout
2022-06-24 01:00:008-KStáhnout
2022-06-24 00:00:008-KStáhnout
2022-05-04 01:00:008-KStáhnout
2022-05-04 01:00:0010-QStáhnout
2022-05-04 00:00:008-KStáhnout
2022-05-04 00:00:0010-QStáhnout
2022-04-28 01:00:008-KStáhnout
2022-04-28 00:00:008-KStáhnout
2022-04-26 01:00:008-KStáhnout
2022-04-26 00:00:008-KStáhnout
2022-02-11 00:00:008-KStáhnout
2022-02-10 23:00:008-KStáhnout
2022-02-08 00:00:008-KStáhnout
2022-02-08 00:00:0010-KStáhnout
2022-02-07 23:00:008-KStáhnout
2022-02-07 23:00:0010-KStáhnout
2022-01-24 00:00:008-KStáhnout
2022-01-23 23:00:008-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2021-11-30 00:00:008-KStáhnout
2021-11-29 23:00:008-KStáhnout
2021-11-22 00:00:008-KStáhnout
2021-11-21 23:00:008-KStáhnout
2021-11-10 00:00:008-KStáhnout
2021-11-09 23:00:008-KStáhnout
2021-11-05 00:00:008-KStáhnout
2021-11-04 23:00:008-KStáhnout
2021-11-02 00:00:008-KStáhnout
2021-11-02 00:00:0010-QStáhnout
2021-11-01 23:00:008-KStáhnout
2021-11-01 23:00:0010-QStáhnout
2021-09-17 01:00:008-KStáhnout
2021-09-17 00:00:008-KStáhnout
2021-08-03 01:00:008-KStáhnout
2021-08-03 01:00:0010-QStáhnout
2021-08-03 00:00:008-KStáhnout
2021-08-03 00:00:0010-QStáhnout
2021-06-25 01:00:008-KStáhnout
2021-06-25 00:00:008-KStáhnout
2021-05-04 01:00:008-KStáhnout
2021-05-04 01:00:0010-QStáhnout
2021-05-04 00:00:008-KStáhnout
2021-05-04 00:00:0010-QStáhnout
2021-03-31 01:00:008-KStáhnout
2021-03-31 00:00:008-KStáhnout
2021-02-09 00:00:008-KStáhnout
2021-02-09 00:00:0010-KStáhnout
2021-02-08 23:00:008-KStáhnout
2021-02-08 23:00:0010-KStáhnout
2021-01-11 00:00:008-KStáhnout
2021-01-10 23:00:008-KStáhnout
2020-11-30 00:00:008-KStáhnout
2020-11-29 23:00:008-KStáhnout
2020-11-12 00:00:008-KStáhnout
2020-11-11 23:00:008-KStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-05 00:00:0010-QStáhnout
2020-11-04 23:00:008-KStáhnout
2020-11-04 23:00:0010-QStáhnout
2020-08-04 01:00:008-KStáhnout
2020-08-04 01:00:0010-QStáhnout
2020-08-04 00:00:008-KStáhnout
2020-08-04 00:00:0010-QStáhnout
2020-06-12 01:00:008-KStáhnout
2020-06-12 00:00:008-KStáhnout
2020-05-15 01:00:008-KStáhnout
2020-05-15 00:00:008-KStáhnout
2020-05-05 01:00:008-KStáhnout
2020-05-05 01:00:0010-QStáhnout
2020-05-05 00:00:008-KStáhnout
2020-05-05 00:00:0010-QStáhnout
2020-03-09 00:00:008-KStáhnout
2020-03-09 00:00:0010-KStáhnout
2020-03-08 23:00:008-KStáhnout
2020-03-08 23:00:0010-KStáhnout
2020-02-14 00:00:008-KStáhnout
2020-02-13 23:00:008-KStáhnout
2020-02-12 00:00:008-KStáhnout
2020-02-11 23:00:008-KStáhnout
2020-01-13 00:00:008-KStáhnout
2020-01-12 23:00:008-KStáhnout
2019-12-16 00:00:008-KStáhnout
2019-12-15 23:00:008-KStáhnout
2019-12-04 00:00:008-KStáhnout
2019-12-03 23:00:008-KStáhnout
2019-11-26 00:00:008-KStáhnout
2019-11-25 23:00:008-KStáhnout
2019-11-13 00:00:008-KStáhnout
2019-11-12 23:00:008-KStáhnout
2019-11-04 00:00:008-KStáhnout
2019-11-04 00:00:0010-QStáhnout
2019-11-03 23:00:008-KStáhnout
2019-11-03 23:00:0010-QStáhnout
2019-10-29 00:00:008-KStáhnout
2019-10-28 23:00:008-KStáhnout
2019-09-30 01:00:008-KStáhnout
2019-09-30 00:00:008-KStáhnout
2019-08-15 01:00:008-KStáhnout
2019-08-15 00:00:008-KStáhnout
2019-08-13 01:00:008-KStáhnout
2019-08-13 00:00:008-KStáhnout
2019-08-02 01:00:008-KStáhnout
2019-08-02 01:00:0010-QStáhnout
2019-08-02 00:00:008-KStáhnout
2019-08-02 00:00:0010-QStáhnout
2019-07-08 01:00:008-KStáhnout
2019-07-08 00:00:008-KStáhnout
2019-06-13 01:00:008-KStáhnout
2019-06-13 00:00:008-KStáhnout
2019-06-11 01:00:008-KStáhnout
2019-06-11 00:00:008-KStáhnout
2019-05-09 01:00:008-KStáhnout
2019-05-09 01:00:0010-QStáhnout
2019-05-09 00:00:008-KStáhnout
2019-05-09 00:00:0010-QStáhnout
2019-05-03 01:00:008-KStáhnout
2019-05-03 00:00:008-KStáhnout
2019-03-14 00:00:008-KStáhnout
2019-03-14 00:00:0010-KStáhnout
2019-03-13 23:00:008-KStáhnout
2019-03-13 23:00:0010-KStáhnout
2019-03-04 00:00:008-KStáhnout
2019-03-03 23:00:008-KStáhnout
2019-02-22 00:00:008-KStáhnout
2019-02-21 23:00:008-KStáhnout
2018-11-08 00:00:008-KStáhnout
2018-11-08 00:00:0010-QStáhnout
2018-11-07 23:00:008-KStáhnout
2018-11-07 23:00:0010-QStáhnout
2018-10-19 01:00:008-KStáhnout
2018-10-19 00:00:008-KStáhnout
2018-08-07 01:00:008-KStáhnout
2018-08-07 01:00:0010-QStáhnout
2018-08-07 00:00:008-KStáhnout
2018-08-07 00:00:0010-QStáhnout
2018-06-04 01:00:008-KStáhnout
2018-06-04 00:00:008-KStáhnout
2018-05-31 01:00:008-KStáhnout
2018-05-31 00:00:008-KStáhnout
2018-05-21 01:00:008-KStáhnout
2018-05-21 00:00:008-KStáhnout
2018-05-08 01:00:008-KStáhnout
2018-05-08 01:00:0010-QStáhnout
2018-05-08 00:00:008-KStáhnout
2018-05-08 00:00:0010-QStáhnout
2018-03-28 01:00:008-KStáhnout
2018-03-28 01:00:0010-KStáhnout
2018-03-28 00:00:008-KStáhnout
2018-03-28 00:00:0010-KStáhnout
2017-11-14 00:00:008-KStáhnout
2017-11-14 00:00:0010-QStáhnout
2017-11-13 23:00:008-KStáhnout
2017-11-13 23:00:0010-QStáhnout
2017-10-05 01:00:008-KStáhnout
2017-10-05 00:00:008-KStáhnout
preloader